Teneligliptin 20 mg

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 2

Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes

CompletedNCT00628212

Tanabe Pharma CorporationType 2 Diabetes

Start: 2008-01-31End: 2009-01-31Updated: 2026-01-02

Phase 3

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

CompletedNCT00998881

Tanabe Pharma CorporationType 2 Diabetes Mellitus

Start: 2009-09-30End: 2010-06-30Updated: 2026-01-02